DBV Technologies
Publicly owned French biopharmaceutical firm headquartered in Bagneux, France
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood.
Nº Q5204430 ★★
Uncommon · Organizations
DBV Technologies
Publicly owned French biopharmaceutical firm headquartered in Bagneux, France
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood.
From Wikipedia
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.
Text: Wikipédia, CC BY-SA 4.0. ·
Related cards
-
Biogen
American multinational biotechnology company
Nº Q864338 ★★
Not listed
-
A
AbCellera
Company in Vancouver, Canada
Nº Q30271491 ★
Not listed
-
B
Bioderma
Company in Lyon, France
Nº Q16951811 ★
Not listed
-
D
Debiopharm
Biopharmaceutical group
Nº Q3020834 ★
Not listed
-
Allergan
Irish tax-registered pharmaceutical company
Nº Q906187 ★
Not listed
-
S
Stallergenes Greer
Biopharmaceutical company
Nº Q3496440 ★
Not listed